BIOCRYST PHARMACEUTICALS INC (BCRX) Top Institutional Shareholders
BIOCRYST PHARMACEUTICALS INC (BCRX) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $2.29B in BCRX holdings during the latest filing period.
Blackrock, Inc. is currently the largest disclosed institutional shareholder of BCRX tracked by InsiderSet, reporting ownership valued at approximately $215.64M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $202.73M, representing an estimated loss of -5.99% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 51% of the total disclosed BCRX value among the investors covered in this analysis. Major shareholders include Blackrock, Inc., Ra Capital Management, L.P., Deerfield Management Company, L.P., and several other long-term asset managers with concentrated positions in BIOCRYST PHARMACEUTICALS INC (BCRX).
This page ranks the largest institutional BCRX shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
296
Total Reported Value
$2.29B
Largest Holder
Blackrock, Inc.
Largest Position
$215.64M
Insider Transactions (90d)
0
Latest Filing Quarter
Q1 2026
New Institutional Positions
110
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Blackrock, Inc. | 0.00% | 22,650,988 | $215,637,401 | $202,726,343 | -$12,911,058 | -5.99% | |
| Ra Capital Management, L.P. | 1.60% | 15,827,186 | $150,674,811 | $141,653,315 | -$9,021,496 | -5.99% | |
| Deerfield Management Company, L.P. | 1.69% | 15,038,000 | $143,161,760 | $134,590,100 | -$8,571,660 | -5.99% | |
| State Street Corp | 0.00% | 12,208,360 | $116,223,587 | $109,264,822 | -$6,958,765 | -5.99% | |
| Vanguard Portfolio Management Llc | 0.01% | 11,244,625 | $107,048,830 | $100,639,394 | -$6,409,436 | -5.99% | |
| Vanguard Capital Management Llc | 0.00% | 11,135,762 | $106,012,454 | $99,665,070 | -$6,347,384 | -5.99% | |
| Tcg Crossover Management, Llc | 3.00% | 11,020,968 | $104,919,615 | $98,637,664 | -$6,281,951 | -5.99% | |
| Janus Henderson Group Plc | 0.04% | 8,908,506 | $84,853,520 | $79,731,129 | -$5,122,391 | -6.04% | |
| Perceptive Advisors Llc | 1.40% | 7,434,033 | $70,771,994 | $66,534,595 | -$4,237,399 | -5.99% | |
| Vestal Point Capital, Lp | 1.87% | 7,025,000 | $66,878,000 | $62,873,750 | -$4,004,250 | -5.99% | |
| Two Sigma Investments, Lp | 0.05% | 6,392,628 | $60,857,819 | $57,214,021 | -$3,643,798 | -5.99% | |
| Geode Capital Management, Llc | 0.00% | 5,782,776 | $55,063,276 | $51,755,845 | -$3,307,431 | -6.01% | |
| Kynam Capital Management, Lp | 3.43% | 5,680,795 | $54,081,168 | $50,843,115 | -$3,238,053 | -5.99% | |
| Bank Of America Corp | 0.00% | 5,091,765 | $48,473,603 | $45,571,297 | -$2,902,306 | -5.99% | |
| Aberdeen Group Plc | 0.08% | 5,040,670 | $47,987,178 | $45,113,997 | -$2,873,182 | -5.99% | |
| Ubs Group Ag | 0.01% | 4,943,994 | $47,066,823 | $44,248,746 | -$2,818,077 | -5.99% | |
| Frazier Life Sciences Management, L.P. | 0.98% | 4,009,240 | $38,167,965 | $35,882,698 | -$2,285,267 | -5.99% | |
| Royalty Pharma Sub-Manager, Llc | 21.19% | 3,846,154 | $36,615,386 | $34,423,078 | -$2,192,308 | -5.99% | |
| Nuveen, Llc | 0.01% | 3,819,263 | $36,359,384 | $34,182,404 | -$2,176,980 | -5.99% | |
| Eversept Partners, Lp | 1.91% | 3,039,820 | $28,939,086 | $27,206,389 | -$1,732,697 | -5.99% | |
| Rfg Advisory, Llc | 0.50% | 2,870,700 | $27,329,064 | $25,692,765 | -$1,636,299 | -5.99% | |
| Susquehanna International Group, Llp | 0.03% | 2,815,304 | $26,801,694 | $25,196,971 | -$1,604,723 | -5.99% | |
| Fisher Asset Management, Llc | 0.01% | 2,733,253 | $26,020,567 | $24,462,614 | -$1,557,953 | -5.99% | |
| Dimensional Fund Advisors Lp | 0.01% | 2,690,651 | $25,614,944 | $24,081,326 | -$1,533,618 | -5.99% | |
| Charles Schwab Investment Management Inc | 0.00% | 2,350,405 | $22,375,856 | $21,036,125 | -$1,339,731 | -5.99% | |
| Goldman Sachs Group Inc | 0.00% | 2,347,443 | $22,347,654 | $21,009,615 | -$1,338,039 | -5.99% | |
| Candriam S.C.A. | 0.11% | 2,286,841 | $21,770,726 | $20,467,227 | -$1,303,499 | -5.99% | |
| Rice Hall James & Associates, Llc | 1.18% | 2,230,105 | $21,230,600 | $19,959,440 | -$1,271,160 | -5.99% | |
| Northern Trust Corp | 0.00% | 2,104,725 | $20,036,982 | $18,837,289 | -$1,199,693 | -5.99% | |
| Morgan Stanley | 0.00% | 2,022,988 | $19,258,852 | $18,105,743 | -$1,153,109 | -5.99% | |
| Nantahala Capital Management, Llc | 1.18% | 1,987,397 | $18,920,019 | $17,787,203 | -$1,132,816 | -5.99% | |
| Stifel Financial Corp | 0.02% | 1,825,184 | $17,375,751 | $16,335,397 | -$1,040,354 | -5.99% | |
| Parkman Healthcare Partners Llc | 1.69% | 1,708,099 | $16,261,102 | $15,287,486 | -$973,616 | -5.99% | |
| Vanguard Fiduciary Trust Co | 0.00% | 1,664,297 | $15,844,107 | $14,895,458 | -$948,649 | -5.99% | |
| Orbimed Advisors Llc | 0.30% | 1,425,200 | $13,567,904 | $12,755,540 | -$812,364 | -5.99% | |
| Legal & General Group Plc | 0.00% | 1,411,199 | $13,434,615 | $12,630,231 | -$804,384 | -5.99% | |
| Schonfeld Strategic Advisors Llc | 0.10% | 1,337,693 | $12,734,836 | $11,972,352 | -$762,484 | -5.99% | |
| Invesco Ltd. | 0.00% | 1,308,813 | $12,459,899 | $11,713,876 | -$746,023 | -5.99% | |
| Bnp Paribas Financial Markets | 0.01% | 1,302,257 | $12,397,487 | $11,655,200 | -$742,287 | -5.99% | |
| Man Group Plc | 0.03% | 1,293,300 | $12,312,216 | $11,575,035 | -$737,181 | -5.99% | |
| Healthcare Of Ontario Pension Plan Trust Fund | 0.02% | 1,227,040 | $11,681,421 | $10,982,008 | -$699,413 | -5.99% | |
| Jupiter Asset Management Ltd | 0.06% | 1,196,371 | $11,389,452 | $10,707,520 | -$681,932 | -5.99% | |
| Citadel Advisors Llc | 0.01% | 1,018,743 | $9,698,433 | $9,117,750 | -$580,683 | -5.99% | |
| Jacobs Levy Equity Management, Inc | 0.04% | 1,004,373 | $9,561,631 | $8,989,138 | -$572,493 | -5.99% | |
| Elmind Capital, Lp | 2.70% | 1,000,000 | $9,520,000 | $8,950,000 | -$570,000 | -5.99% | |
| Rosalind Advisors, Inc. | 3.60% | 923,057 | $8,787,503 | $8,261,360 | -$526,143 | -5.99% | |
| Sphera Funds Management Ltd. | 1.42% | 866,464 | $8,248,737 | $7,754,853 | -$493,884 | -5.99% | |
| Deutsche Bank Ag\ | 0.00% | 821,367 | $7,819,414 | $7,351,235 | -$468,179 | -5.99% | |
| First Trust Advisors Lp | 0.01% | 800,900 | $7,624,568 | $7,168,055 | -$456,513 | -5.99% | |
| Renaissance Technologies LLC | Jim Simons | 0.01% | 776,990 | $7,396,945 | $6,954,060 | -$442,885 | -5.99% |
Frequently asked questions about BCRX
Who owns the most BCRX stock?
The largest holders of BCRX are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for BIOCRYST PHARMACEUTICALS INC (BCRX).
Is BCRX widely held by superinvestors?
Many widely followed stocks like BCRX appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly BCRX is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.